Pedlo, Monina B.
HRN: 15-09-37 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/11/2024
09/18/2024
IV
400mg
Every 8 Hours
Urosepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes